» Articles » PMID: 36145436

MicroRNA-122 Regulation of HCV Infections: Insights from Studies of MiR-122-Independent Replication

Overview
Journal Pathogens
Date 2022 Sep 23
PMID 36145436
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the advancement in antiviral therapy, Hepatitis C remains a global health challenge and one of the leading causes of hepatitis related deaths worldwide. Hepatitis C virus, the causative agent, is a positive strand RNA virus that requires a liver specific microRNA called miR-122 for its replication. Unconventional to the canonical role of miRNAs in translation suppression by binding to 3'Untranslated Region (UTR) of messenger RNAs, miR-122 binds to two sites on the 5'UTR of viral genome and promotes viral propagation. In this review, we describe the unique relationship between the liver specific microRNA and HCV, the current knowledge on the mechanisms by which the virus uses miR-122 to promote the virus life cycle, and how miR-122 impacts viral tropism and pathogenesis. We will also discuss the use of anti-miR-122 therapy and its impact on viral evolution of miR-122-independent replication. This review further provides insight into how viruses manipulate host factors at the initial stage of infection to establish a successful infection.

Citing Articles

The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.

Yuan H, Xu R, Li S, Zheng M, Tong Q, Xiang M MedComm (2020). 2025; 6(3):e70121.

PMID: 40060195 PMC: 11890166. DOI: 10.1002/mco2.70121.


The Role of MicroRNAs in Liver Functioning: from Biogenesis to Therapeutic Approaches (Review).

Kozlov D, Rodimova S, Kuznetsova D Sovrem Tekhnologii Med. 2025; 15(5):54-79.

PMID: 39967915 PMC: 11832066. DOI: 10.17691/stm2023.15.5.06.


Development and characterization of a miRNA-responsive circular RNA expression system with cell type specificity.

Ma Y, Mao Y, Luo S, Zuo W, Gao P, Ying B Mol Ther Nucleic Acids. 2025; 36(1):102450.

PMID: 39967851 PMC: 11834102. DOI: 10.1016/j.omtn.2025.102450.


MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis.

Niazi S, Magoola M Int J Mol Sci. 2024; 25(23.

PMID: 39684593 PMC: 11641023. DOI: 10.3390/ijms252312883.


Extracellular Vesicles in Viral Liver Diseases.

Kouroumalis E, Tsomidis I, Voumvouraki A Viruses. 2024; 16(11).

PMID: 39599900 PMC: 11598962. DOI: 10.3390/v16111785.


References
1.
Schult P, Roth H, Adams R, Mas C, Imbert L, Orlik C . microRNA-122 amplifies hepatitis C virus translation by shaping the structure of the internal ribosomal entry site. Nat Commun. 2018; 9(1):2613. PMC: 6031695. DOI: 10.1038/s41467-018-05053-3. View

2.
Shimakami T, Yamane D, Welsch C, Hensley L, Jangra R, Lemon S . Base pairing between hepatitis C virus RNA and microRNA 122 3' of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol. 2012; 86(13):7372-83. PMC: 3416334. DOI: 10.1128/JVI.00513-12. View

3.
Thakral S, Ghoshal K . miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2014; 15(2):142-50. PMC: 4439190. DOI: 10.2174/1566523214666141224095610. View

4.
Walsh D, Mathews M, Mohr I . Tinkering with translation: protein synthesis in virus-infected cells. Cold Spring Harb Perspect Biol. 2012; 5(1):a012351. PMC: 3579402. DOI: 10.1101/cshperspect.a012351. View

5.
Vermehren J, Sarrazin C . New HCV therapies on the horizon. Clin Microbiol Infect. 2010; 17(2):122-34. DOI: 10.1111/j.1469-0691.2010.03430.x. View